New drug development for pediatric oncology

Steven D Weitman, Lisa Carlson, Charles B. Pratt

Research output: Contribution to journalArticle

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalInvestigational New Drugs
Volume14
Issue number1
StatePublished - 1996

Fingerprint

Phase II Clinical Trials
Clinical Trials, Phase I
Antineoplastic Agents
Pediatrics
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Weitman, S. D., Carlson, L., & Pratt, C. B. (1996). New drug development for pediatric oncology. Investigational New Drugs, 14(1), 1-10.

New drug development for pediatric oncology. / Weitman, Steven D; Carlson, Lisa; Pratt, Charles B.

In: Investigational New Drugs, Vol. 14, No. 1, 1996, p. 1-10.

Research output: Contribution to journalArticle

Weitman, SD, Carlson, L & Pratt, CB 1996, 'New drug development for pediatric oncology', Investigational New Drugs, vol. 14, no. 1, pp. 1-10.
Weitman SD, Carlson L, Pratt CB. New drug development for pediatric oncology. Investigational New Drugs. 1996;14(1):1-10.
Weitman, Steven D ; Carlson, Lisa ; Pratt, Charles B. / New drug development for pediatric oncology. In: Investigational New Drugs. 1996 ; Vol. 14, No. 1. pp. 1-10.
@article{ddbec0ea52d343d9924f9e7f56f10777,
title = "New drug development for pediatric oncology",
author = "Weitman, {Steven D} and Lisa Carlson and Pratt, {Charles B.}",
year = "1996",
language = "English (US)",
volume = "14",
pages = "1--10",
journal = "Investigational New Drugs",
issn = "0167-6997",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - New drug development for pediatric oncology

AU - Weitman, Steven D

AU - Carlson, Lisa

AU - Pratt, Charles B.

PY - 1996

Y1 - 1996

UR - http://www.scopus.com/inward/record.url?scp=0029790039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029790039&partnerID=8YFLogxK

M3 - Article

C2 - 8880388

AN - SCOPUS:0029790039

VL - 14

SP - 1

EP - 10

JO - Investigational New Drugs

JF - Investigational New Drugs

SN - 0167-6997

IS - 1

ER -